Welcome to Crene Biotechnology!


Product :

Ombitasvir ABT-267

Ombitasvir ABT-267 1258226-87-7
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:Ombitasvir ABT-267 Purity:98% min
CAS NO:1258226-87-7 Solubility:DMSO : ≥ 33 mg/mL (36.91 mM)
Molecular Formula:C50H67N7O8 Package:Package according to customer requirements
Molecular Weight:894.109 Storage:Store at -20℃
Quality control
Ombitasvir, also known as ABT-267, is a NS5A inhibitor, and is an antiviral drug for the treatment of hepatitis C virus (HCV) infection. In the United States, it is approved by the Food and Drug Administration for use in combination with paritaprevir, ritonavir and dasabuvir in the product Viekira Pak. Ombitasvir acts by inhibiting the HCV protein NS5A.
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021Taizhou Crene Biotechnology Co., Ltd.

Address:Economic Developed Zone of Taizhou Zhejiang China.